• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/18/2019
Event Type  malfunction  
Manufacturer Narrative
Journal article: impact of late stent malapposition after drug-eluting stent implantation on long-term clinical outcomes.Journal: elsevier year: 2019 ref: doi: https://doi.Org/10.1016/j.Atheroscl.Age or date of birth: average age.Sex: majority gender.Date of event: date of publication.The endeavor resolute rx coronary drug eluting stent is similar to the resolute integrity rx coronary drug eluting stent which is marketed in the us.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Long-term clinical outcomes of late stent malapposition (lsm) detected by optical coherence tomography (oct) were evaluated in a total of 428 patients who were selected from previous randomized oct studies.These patients were assigned to one of two groups based on the presence (n = 136) or absence (n = 292) of lsm on follow-up oct images.123 endeavor resolute drug eluting stents were among a number of des implanted.Post implantation 32 endeavour resolute des devices were found to have late stent malapposition.The left anterior descending artery was the only lesional characteristic reported.Follow-up oct was performed post-intervention.Clinical events included target vessel-related myocardial infarction, target vessel r evascularization, target lesion-related myocardial infarction, target lesion revascularization.It was noted that the presence of oct-detected lsm was not associated with adverse clinical events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RESOLUTE RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8978889
MDR Text Key157108894
Report Number9612164-2019-03814
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/10/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/15/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age62 YR
-
-